References
- Naito R., Yokoyama K. Perfluorochemical blood substitutes. Fluosol-43, Fluosol-DA 20% and 35%. Technical Information Series No. 5. The Green Cross Corporation. June 30, 1978; 1–177
- Ohyanagi H., Toshima K. M, Sekita M., Okamoto T., Itoh T., Mitsuno R., Naito T., Suyama K., Yokoyama. Clinical studies of perfluorochemical whole blood substitutes: Safety of Fluosol-DA(20%) in normal human volunteers. Clinical Therapeutics 2 1979; 306: 312
- Mitsuno T., Ohyanagi H., Naito R. Clinical studies of perfluorochemical whole blood substitute (Fluosol-DA)-Summary of 186 cases. Ann. Surg. 1982; 195: 60–69
- Keipert P. E. S., Chang T. M. In vivo assessment of pyridoxylated crosslinked polyhemoglobin as an artificial red cell substitute in rats. Trans Am Soc Artif Intern Organs 1983; 29: 329–333
- Sehgal L. R., Gould S. A., Rosen A. L., Sehgal H. L., Moss G. S. Polymerized pyridoxylated hemoglobin: A red cell substitute with normal oxygen capacity. Surgery 1984; 95(4)433–438
- Agishi T., Takayam H., Teraoka S., Yamagata K., Kobayashi M, Ota K. Retrieval of artificial blood cells (Perfluorochemical) from whole blood. Trans Am Soc Artif Intern Organs 1983; 29: 456–459
- Agishi T., Yamagata K., Kobayashi M., Teraoka S., Honda H., Ota; K. Normothemic whole body rinse-out utilizing perfluorochemical (PFC)-containing artificial blood. Trans Am Soc Artif Intern Organs 1984; 30: 295–297
- Iwasaki K., Iwashita Y. Preparation and evaluation of hemoglobin-polyethylene glycol conjugate (pyridoxalated polyethylene glycol hemoglobin) as an oxygen-carrying resuscitation fluid. Artificial Organs 1986; 10(5)411–416
- Matsushita M., Iwasaki K., Nasu M., Horiuchi T., Chen J. F., Goldcamp J., Murabayashi S., Malchesky P. S., Nose Y., Iwashita Y. Physiologic effects of pyridoxalated-hemoglobin-polyethylene glycol conjugate solution in exchange transfusion. Trans Am Soc Artif Intern Organs 1986; 32: 490–494
- Klebanoff G., Langdon D., Wien S. Total body washout in hepatic coma. New Engl J Med 1973; 289: 807–815